Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 12.5% in First Half of 2023

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 333.6 million yuan in the first half of 2023, down 12.5% year-on-year.

Meanwhile, the company posted 871.3 million yuan in revenue, down 1.1% year-on-year.

At the end of the reporting period, it had 10 billion yuan in total assets and 428 million yuan in total liabilities, with a liability-to-asset ratio of 4.3%.